fluconazole has been researched along with Adenocarcinoma of Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agalioti, T; Antimisiaris, SG; Eickelberg, O; Giannou, AD; Harokopos, V; Kanellakis, NI; Kardamakis, D; Kati, D; Krontira, AC; Lilis, I; Marazioti, A; Meiners, S; Nikolouli, E; Papadakis, A; Papadia, K; Pepe, M; Psallidas, I; Snyder, LA; Spella, M; Spiropoulou, N; Stamou, P; Stathopoulos, GT; Voulgaridis, A; Vreka, M; Zazara, DE | 1 |
1 other study(ies) available for fluconazole and Adenocarcinoma of Lung
Article | Year |
---|---|
Mutant KRAS promotes malignant pleural effusion formation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Chemokine CCL2; Chickens; Chorioallantoic Membrane; Female; HEK293 Cells; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Myeloid Cells; Pleural Cavity; Pleural Effusion, Malignant; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Spleen; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |